username : password :
Register | Forgot Password ?
Sitemap | FAQ's
Home | About Us | News | Event | Forum | Gallery | Membership | Partners | Contact Us

Article

Home » Article » Research » Others » Abstrak Ilmiah Scientific Meeting INASH 2012

Abstrak Ilmiah Scientific Meeting INASH 2012

1. Treatment in Hypertension : Non-Pharmacologic & Pharmacologic Approach
    By. Amanda Tiksnadi, MD ............................................................................... 1

2. Blood  Pressure  Variability : The Importance in Hypertension And How to
    Control It

    By. Arieska Ann Soenarta,MD,FIHA  ................................................................. 2

3. The Collaboration In Fighting Hypertension & Its Complications
    Cardiologist’s Perspective

    By. Anna Ulfah Rahajoe
    President of Indonesian Heart Association ......................................................... 5

4. Hypertension Syndrome : Challenge for Better Outcomes
    By. Dr Arieska Ann Soenarta .......................................................................... 10
 
5. Vascular Biology in Hypertension : Impact on Hemorheology
    By. Ario Soeryo Kuncoro, MD ......................................................................... 12

6. New Insight And Results From Re-Ly Trial And New Treatment
    Guidelines For  In Spaf : The Future Id Now

    By. Bambang Budiono, MD
    Heart & Vascular Center- Awal BrosHospital Makassar ..................................... 13

7. Which group of Patients will Benefit Most in Hypertension Management with
    Beta Blockers

    By. Budi Yuli Setianto, MD, FIHA, FINASIM, FAsCC
    Department of Cardiology and Vascular Medicine Faculty of Medicine
    Gadjah Mada University – Sardjito Hospital Yogyakarta
..................................... 14

8. Achieving Better BP Control With Better Adherence
    By. Eka Harmeiwaty
    National Cardiovascular Center, Harapan Kita Hospital, Jakarta  ........................ 15

9. Metode Pengukuran Tekanan Darah Yang Baik ?
    By. Ekawati Dani yulianti ................................................................................ 16

10. Ischemic  Preconditioning  in  Diabetic  Patients
     By. Erwinanto, MD
     Departmentof Cardiology and Vascular Medicine Division of Cardiovascular,
     Department of Internal Medicine Universitas Padjadjaran School
     of Medicine Hasan Sadikin Hospital Bandung
.................................................. 17

11. Optimising Blood Pressure Control To P rotect Microvascular Involvement
     By. A. Fauzi Yahya
     Department of Cardiology and Vascular Medicine
     Medical School of Padjadjaran University
........................................................ 18

12. Stroke Prevention in Atrial Fibrillation : Where are we now ?
     By. Hendro Susilo
     Dept of Neurology Airlangga School of Medicine
     Dr. Soetomo Hospital Surabaya
  .................................................................... 20

13. Risk Assessment of Thromboembolism in Atrial Fibrillation
     By. Iwan Dakota MD, FIHA, FACC, FESC, FSCAI
     Dept. Cardiology and Vascular Medicine, Faculty of Medicine
     University of Indonesia National Cardiovascular Center
     Harapan Kita Hospital
................................................................................... 22

14. The Pathophysiology of Hypertension
     By. Januar Wibawa Martha
     Department of Cardiology and Vascular Medicine,
    Padjadjaran University, Bandung
..................................................................... 24

15. Neurologic Aspects in the Treatment of Hypertensive Crisis
     By. Mursyid Bustami, MD
     Neurology Department University of Indonesia ................................................ 25

16. Cardiorenal Anemia Syndrome : A Cardiologist’s Perspective
     By. Nani Hersunarti, MD, FIHA
     Clinical Cardiology and Critical Care Division National Cardiovascular Center
     Harapan Kita Department of Cardiology & Vascular Medicine Faculty of Medicine
     Universitas Indonesia
................................................................................... 27

17. Penggunaan Statin Pada Penyakit Ginjal Kronik : Apakah Aman ?
     By. Dr.dr. Parlindungan Siregar SpPD.KGH .................................................... 28

18.Classification And Cardiovascular Risk Assesment In
    Hypertension

    By. Pringgodigdo Nugroho
    Nephrology & Hypertension Division, Departmen of Internal Medicine
    Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine University of Indonesia
.. 32

19. Keseimbangan Air Dan Natrium
      By. Parlindungan Siregar ............................................................................. 34

20. Beta Blockers in the Management of Hypertension: An Asian Perspective
     By. Ria Bandiara
    Div of Nephrology & Hypertension, Internal Medicine Department Faculty of Medicine
     Unpad Hasan Sadikin Hospital Bandung
....................................................... 39

21. Resistant Hypertension Resistant Hypertension" untuk How to session
     By. Rossana Barack .................................................................................... 40

22. Evolving The Future Of Single Pill Combination In Anti
     Hypertension Therapy

     By. Rubin Surachno
     Nephrology and Hypertension Sub.Div. Department of Internal Medicine
     Dr Hasan Sadikin General Hospital Padjadjaran University Bandung .
................ 41

23. Arb In BP Lowering : Are There Any Any Pleiotropic Effects ?
     By. Santoso Karo Karo ............................................................................... 43

24. Hypertension in CKD  patients Tunggul
     By. Diapari Situmorang  MD
     Cikini CCI Hospital, MRCC Hospital – Jakarta ................................................ 45

25. Hypertension in Elderly
     By. Yuda Turana
     Dept of Neurology, Medical Faculty of Atma Jaya
     Indonesia Catholic University,Jakarta
     Center of Health Research, Atma Jaya Indonesia Catholic University, Jakarta
... 46

26. Treating Hypertensive Diabetic Patients : What Should We Know ?
     By. Zulkhair Ali
     Div. Nephrology & Hypertension, Dept. Medicine, Medical Faculty
     Sriwijaya University, Moh. Hoesin Hospital Palembang
................................... 47

27. Blood  Pressure  Lowering  or  Cardiovascular Protection :  Which  One
     Will  You Choose ?

     By. Yudi Her Oktaviono ............................................................................... 48

28. The Neuroprotective Effects Of Calcium Channel
     Blockers In Stroke
     By. Moh Hasan Machfoed
     Department of Neurology Medical Faculty of Airlangga University
     Dr. Soetomo Hospital Surabaya ..
................................................................ 50

29. Peran Anti Hipertensi Kombinasi Dalam Meningkatkan Efektifitas
     Terapi Fokus pada kombinasi Olmesartan dan Amlodipin

     By. Ketut Suwitra,
     Divisi Ginjal dan Hipertensi bagian SMF Ilmu Penyakit Dalam FK Unud
     RSUP Sanglah Denpasar
............................................................................ 51

30. Sodium  Dan  Hipertensi Aspek Patogenesis Dan Tata Laksana
     By. Ketut Suwitra
     Divisi Ginjal dan Hipertensi Bagian SMF Ilmu Penyakit Dalam FK Unud
     RSUP Sanglah Denpasar
........................................................................... 52

31. Are All Calcium Channel Blockers (CCBs) the same ? Lercanidipine and
     Renoprotection

     By. Mohammad Yogiantoro
     Sub Departemen Ginjal & Hipertensi, Departemen – SMF Ilmu Penyakit Dalam
     FK UNAIR RSUD Dr. Soetomo
.................................................................... 53

32. Ginjal dan Hipertensi V.V RP Sidabutar Memorial Lecture.
     By. Harun Rasyid Lubis.
     Divisi Nefrologi dan HipertensiDepartemen Ilmu Penyakit Dalam
     FK- USU Medan
........................................................................................ 55

33. Neurologist's Perspective On The Collaboration In
     Fighting Hypertension And Its Complications

     By. Moh Hasan Machfoed
     Department of Neurology Medical Faculty of Airlangga University
     Dr. Soetomo Hospital – Surabaya
................................................................ 59

34. Erythropoiesis Stimulating Agents (ESA) and Hypertension
     By. Suhardjono
     Div of Nephrology and Hypertension, Dept of Medicine Faculty of Medicine
     University of Indonesia, RS Dr Cipto Mangunkusumo
....................................... 60


[ Download PDF ]

Article
Abstrak Ilmiah Scientific Meeting INASH 2012
The Association between Hypertension and Dementia in the Elderly
Guidelines for Treatment of Hypertension in the Elderly

.more article...